Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Sponsored

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Posted

53

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Please log in to like, share and comment!

Four crusher and brick factories shut down in Mandandeupur for tax evasion

KATHMANDU: The Mandandeupur Municipality in Kavrepalanchok district has shut down four crusher...

By 0 1

‘Standing silent as Israel annihilates a nation’: Congress slams government over UN Gaza vote; says abstention reversed moral legacy

By 0 1

With 99% compliance, here’s what the UAE is doing to protect workers in peak summer heat

The UAE's Midday Work Ban starts June 15. It stops outdoor work from 12:30 PM to 3:00 PM until...

By 0 25

Ahmedabad plane crash: Air India, AI Express drop flight number '171' – report

By 0 25

Nepal announces squad for T20I tri-series in Scotland

KATHMANDU: Nepal has announced its squad for the upcoming T20I tri-series against Scotland and...

By 0 37